175 related articles for article (PubMed ID: 34707394)
1. Multi-Omics Analysis Identified TMED2 as a Shared Potential Biomarker in Six Subtypes of Human Cancer.
Sial N; Saeed S; Ahmad M; Hameed Y; Rehman A; Abbas M; Asif R; Ahmed H; Hussain MS; Rehman JU; Atif M; Khan MR
Int J Gen Med; 2021; 14():7025-7042. PubMed ID: 34707394
[TBL] [Abstract][Full Text] [Related]
2. A pan-cancer analysis of GINS complex subunit 4 to identify its potential role as a biomarker in multiple human cancers.
Usman M; Okla MK; Asif HM; AbdElgayed G; Muccee F; Ghazanfar S; Ahmad M; Iqbal MJ; Sahar AM; Khaliq G; Shoaib R; Zaheer H; Hameed Y
Am J Cancer Res; 2022; 12(3):986-1008. PubMed ID: 35411239
[TBL] [Abstract][Full Text] [Related]
3. SHMT2 is Associated with Tumor Purity, CD8+ T Immune Cells Infiltration, and a Novel Therapeutic Target in Four Different Human Cancers.
Usman M; Hameed Y; Ahmad M; Iqbal MJ; Maryam A; Mazhar A; Naz S; Tanveer R; Saeed H; Bint-E-Fatima ; Ashraf A; Hadi A; Hameed Z; Tariq E; Aslam AS
Curr Mol Med; 2023; 23(2):161-176. PubMed ID: 35023455
[TBL] [Abstract][Full Text] [Related]
4. Integrative analysis reveals methylenetetrahydrofolate dehydrogenase 1-like as an independent shared diagnostic and prognostic biomarker in five different human cancers.
Sial N; Rehman JU; Saeed S; Ahmad M; Hameed Y; Atif M; Rehman A; Asif R; Ahmed H; Hussain MS; Khan MR; Ambreen A; Ambreen A
Biosci Rep; 2022 Jan; 42(1):. PubMed ID: 34908119
[TBL] [Abstract][Full Text] [Related]
5. Up-regulation of GINS1 highlighted a good diagnostic and prognostic potential of survival in three different subtypes of human cancer.
Ahmad M; Hameed Y; Khan M; Usman M; Rehman A; Abid U; Asif R; Ahmed H; Hussain MS; Rehman JU; Asif HM; Arshad R; Atif M; Hadi A; Sarfraz U; Khurshid U
Braz J Biol; 2021; 84():e250575. PubMed ID: 34852135
[TBL] [Abstract][Full Text] [Related]
6. TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma.
Gao W; Zhang ZW; Wang HY; Li XD; Peng WT; Guan HY; Liao YX; Liu A
Front Genet; 2022; 13():895281. PubMed ID: 35754792
[No Abstract] [Full Text] [Related]
7. Decoding signal transducer and activator of transcription 1 across various cancers through data mining and integrative analysis.
Munir H; Rana AT; Faheem M; Almutairi SM; Siddique T; Asghar S; Abdel-Maksoud MA; Mubarak A; Elkhamisy FAA; Studenik CR; Yaz H
Am J Transl Res; 2022; 14(6):3638-3657. PubMed ID: 35836889
[TBL] [Abstract][Full Text] [Related]
8. CTHRC1 expression is a novel shared diagnostic and prognostic biomarker of survival in six different human cancer subtypes.
Sial N; Ahmad M; Hussain MS; Iqbal MJ; Hameed Y; Khan M; Abbas M; Asif R; Rehman JU; Atif M; Khan MR; Hameed Z; Saeed H; Tanveer R; Saeed S; Sharif A; Asif HM
Sci Rep; 2021 Oct; 11(1):19873. PubMed ID: 34615943
[TBL] [Abstract][Full Text] [Related]
9. Screening of the novel immune-suppressive biomarkers of TMED family and whether knockdown of TMED2/3/4/9 inhibits cell migration and invasion in breast cancer.
Fang Z; Song YX; Wo GQ; Zhou HL; Li L; Yang SY; Chen X; Zhang J; Tang JH
Ann Transl Med; 2022 Dec; 10(23):1280. PubMed ID: 36618780
[TBL] [Abstract][Full Text] [Related]
10. Decoding the significant diagnostic and prognostic importance of maternal embryonic leucine zipper kinase in human cancers through deep integrative analyses.
Hameed Y
J Cancer Res Ther; 2023 Oct; 19(7):1852-1864. PubMed ID: 38376289
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of TMED2 is an unfavorable prognostic factor in patients with breast cancer.
Lin X; Liu J; Hu SF; Hu X
Cancer Manag Res; 2019; 11():2203-2214. PubMed ID: 31114314
[No Abstract] [Full Text] [Related]
12. A pan-cancer analysis of pituitary tumor-transforming 3, pseudogene.
Li J; Shaikh SN; Uqaili AA; Nasir H; Zia R; Akram MA; Jawad FA; Sohail S; AbdelGawwad MR; Almutairi SM; Elshikh MS; Jamil M; Rasheed RA
Am J Transl Res; 2023; 15(8):5408-5424. PubMed ID: 37692950
[TBL] [Abstract][Full Text] [Related]
13. Characterizing the oncogenic importance and exploring gene-immune cells correlation of ACTB in human cancers.
Li G; Samuel S; Ul Haq SE; Mubarak AS; Studenik CR; Islam A; Aufy M; Kadham MJ; Al-Azzawi AKJ; Abdel-Maksoud MA
Am J Cancer Res; 2023; 13(3):758-777. PubMed ID: 37034229
[TBL] [Abstract][Full Text] [Related]
14. Elucidating cuproptosis-related gene SLC31A1 diagnostic and prognostic values in cancer.
Mi J; Luo J; Zeng H; Zhang H; Jamil M; Abdel-Maksoud MA; Zakri AM; Alfuraydi AA; Zhang N; Xiao M
Am J Transl Res; 2023; 15(10):6026-6041. PubMed ID: 37969191
[TBL] [Abstract][Full Text] [Related]
15. Transmembrane p24 trafficking protein 2 regulates inflammation through the TLR4/NF-κB signaling pathway in lung adenocarcinoma.
Feng L; Cheng P; Feng Z; Zhang X
World J Surg Oncol; 2022 Feb; 20(1):32. PubMed ID: 35135563
[TBL] [Abstract][Full Text] [Related]
16. Decoding the DSCC1 gene as a pan-cancer biomarker in human cancers via comprehensive multi-omics analyses.
Wang J; Gilani SF; Noor N; Ahmed MR; Munazir M; Zubair A; Sultan R; Abdel-Maksoud MA; Saleh IA; Zomot N; Kodous AS; Ibrahim SS; El-Tayeb MA; Aufy M; Zaky MY; Hassan SS; Hameed Y
Am J Transl Res; 2024; 16(3):738-754. PubMed ID: 38586115
[TBL] [Abstract][Full Text] [Related]
17. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors.
Zhao H; Xie R; Zhang C; Lu G; Kong H
Front Genet; 2022; 13():989460. PubMed ID: 36159971
[No Abstract] [Full Text] [Related]
19. ELL associated factor 2 is a potential diagnostic and prognostic indicator: evidence from the in silico and in vitro experiments.
Yu X; Teng JQ; Chen J; Peng C; Guo TR; Dong MW; Hao XL; Li KX; Huo XX; Ren CC
Am J Cancer Res; 2023; 13(6):2572-2587. PubMed ID: 37424805
[TBL] [Abstract][Full Text] [Related]
20. Integrative data mining and meta-analysis to investigate the prognostic role of microRNA-200 family in various human malignant neoplasms: A consideration on heterogeneity.
Yuan L; Bing Z; Yan P; Li R; Wang C; Sun X; Yang J; Shi X; Zhang Y; Yang K
Gene; 2019 Oct; 716():144025. PubMed ID: 31394177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
